Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J]. LANCET, 2005, 365 (9464) : 1054 - 1061

[2] Campbell Peter J, 2005, Hematology Am Soc Hematol Educ Program, P201

[3] Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis [J]. LEUKEMIA, 2006, 20 (02) : 350 - 353

[4] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J]. NATURE, 2005, 434 (7037) : 1144 - 1148

[5] JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia [J]. BLOOD, 2005, 106 (10) : 3370 - 3373

[6] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J]. BLOOD, 2005, 106 (06) : 2162 - 2168

[7] A gain-of-function mutation of JAK2 in myeloproliferative disorders [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790

[8] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J]. CANCER CELL, 2005, 7 (04) : 387 - 397

[9] Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders [J]. LEUKEMIA, 2006, 20 (01) : 168 - 171

[10] Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (04) : 625 - 633

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J]. LANCET, 2005, 365 (9464) : 1054 - 1061

[2] Campbell Peter J, 2005, Hematology Am Soc Hematol Educ Program, P201

[3] Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis [J]. LEUKEMIA, 2006, 20 (02) : 350 - 353

[4] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J]. NATURE, 2005, 434 (7037) : 1144 - 1148

[5] JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia [J]. BLOOD, 2005, 106 (10) : 3370 - 3373

[6] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J]. BLOOD, 2005, 106 (06) : 2162 - 2168

[7] A gain-of-function mutation of JAK2 in myeloproliferative disorders [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790

[8] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J]. CANCER CELL, 2005, 7 (04) : 387 - 397

[9] Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders [J]. LEUKEMIA, 2006, 20 (01) : 168 - 171

[10] Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (04) : 625 - 633